- Home
- ZGN vs CERT Comparison
ZGN vs CERT Comparison
Compare ZGN & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZGN
- CERT
- Stock Information
- Founded
- ZGN 1910
- CERT 2008
- Country
- ZGN Italy
- CERT United States
- Employees
- ZGN N/A
- CERT N/A
- Industry
- ZGN Apparel
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- ZGN Consumer Discretionary
- CERT Technology
- Exchange
- ZGN Nasdaq
- CERT Nasdaq
- Market Cap
- ZGN 2.3B
- CERT 1.9B
- IPO Year
- ZGN N/A
- CERT 2020
- Fundamental
- Price
- ZGN $9.06
- CERT $10.16
- Analyst Decision
- ZGN Buy
- CERT Buy
- Analyst Count
- ZGN 2
- CERT 7
- Target Price
- ZGN $8.05
- CERT $15.17
- AVG Volume (30 Days)
- ZGN 1.9M
- CERT 1.7M
- Earning Date
- ZGN 03-27-2025
- CERT 08-06-2025
- Dividend Yield
- ZGN 1.55%
- CERT N/A
- EPS Growth
- ZGN N/A
- CERT N/A
- EPS
- ZGN 0.31
- CERT N/A
- Revenue
- ZGN $2,015,371,157.00
- CERT $394,498,000.00
- Revenue This Year
- ZGN $0.12
- CERT $11.52
- Revenue Next Year
- ZGN $5.08
- CERT $8.74
- P/E Ratio
- ZGN $28.85
- CERT N/A
- Revenue Growth
- ZGN 2.21
- CERT 9.37
- 52 Week Low
- ZGN $6.05
- CERT $8.64
- 52 Week High
- ZGN $11.52
- CERT $16.88
- Technical
- Relative Strength Index (RSI)
- ZGN 55.43
- CERT 40.10
- Support Level
- ZGN $8.66
- CERT $10.26
- Resistance Level
- ZGN $9.13
- CERT $11.71
- Average True Range (ATR)
- ZGN 0.25
- CERT 0.44
- MACD
- ZGN -0.02
- CERT -0.07
- Stochastic Oscillator
- ZGN 75.13
- CERT 16.86
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.